NCT06467487View on ClinicalTrials.gov

Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2

NACompletedINTERVENTIONAL
Enrollment

214,526

Participants

Timeline

Start Date

September 4, 2024

Primary Completion Date

January 6, 2025

Study Completion Date

January 6, 2025

Conditions
Patient Participation
Interventions
OTHER

Traditional Letter

Patients receive a traditional letter.

OTHER

Direct to Patient Message

Patients receive a direct to patient message via the portal.

OTHER

Optimized Letter

Patients receive an optimized letter.

OTHER

Direct to Patient Message - Optimized

Patients receive an optimized direct to patient message via the portal.

Trial Locations (1)

06511

Yale University, New Haven

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

Yale University

OTHER

NCT06467487 - Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2 | Biotech Hunter | Biotech Hunter